Jan 24, 2022 / 10:00PM GMT
Operator
Thank you for standing by and welcome to the eFFECTOR Therapeutics Pipeline and Business Update. (Operator Instructions). Please be advised that today's conference is being recorded. (Operator Instructions).
I would now like to hand the conference over to your speaker today, Chief Financial Officer Michael Byrnes.
Michael Byrnes - eFFECTOR Therapeutics - Chief Financial Officer
Good afternoon, and thank you for joining us today to review eFFECTOR's multiple pipeline and business updates. Before we start, we encourage you to view the slides for this webcast as well as the press release issued this afternoon. Both of which are accessible on our website in the Investor section.
As shown on Slide 1, during today's presentation, we will be making several forward-looking statements about our business, products and development strategies, and future operating performance. The forward-looking statements are based on our current beliefs and expectations, and speak only as of the date of this presentation, and we undertake no obligation to update such
eFFECTOR Therapeutics Inc Provides Pipeline and Business Updates - Conference Call Transcript
Jan 25, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers